← Every company

CRISPR Therapeutics AG SEC Filings

What CRISPR Therapeutics AG has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

CRSP overview →
Filings on file
125
since Oct 19, 2016
Warning signs
0
none filed
Last results
Aug 3, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Aug 3, 2026
Quarterly report
10-Q
Read ↗
Aug 3, 2026
Results announced
8-K
Read ↗
Jun 4, 2026
Executive or director changeShareholder vote
8-K
Read ↗
May 4, 2026
Quarterly report
10-Q
Read ↗
May 4, 2026
Results announced
8-K
Read ↗
Mar 16, 2026
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Feb 12, 2026
Annual report
10-K
Read ↗
Feb 12, 2026
Results announced
8-K
Read ↗
Nov 10, 2025
Quarterly report
10-Q
Read ↗
Nov 10, 2025
Results announced
8-K
Read ↗
Aug 4, 2025
Quarterly report
10-Q
Read ↗
Aug 4, 2025
Results announced
8-K
Read ↗
Jun 9, 2025
Shareholder vote
8-K
Read ↗
May 19, 2025
Material agreement
8-K
Read ↗
May 6, 2025
Quarterly report
10-Q
Read ↗
May 6, 2025
Results announced
8-K
Read ↗
Mar 26, 2025
Executive or director change
8-K
Read ↗
Feb 11, 2025
Annual report
10-K
Read ↗
Feb 11, 2025
Results announced
8-K
Read ↗
Nov 5, 2024
Quarterly report
10-Q
Read ↗
Nov 5, 2024
Results announced
8-K
Read ↗
Aug 5, 2024
Quarterly report
10-Q
Read ↗
Aug 5, 2024
Results announced
8-K
Read ↗
Jun 3, 2024
Executive or director changeShareholder vote
8-K
Read ↗
May 23, 2024
Executive or director change
8-K
Read ↗
May 8, 2024
Quarterly report
10-Q
Read ↗
May 8, 2024
Results announced
8-K
Read ↗
Feb 21, 2024
Annual report
10-K
Read ↗
Feb 21, 2024
Results announced
8-K
Read ↗
Feb 13, 2024
Material agreement
8-K
Read ↗
Dec 19, 2023
Executive or director change
8-K
Read ↗
Dec 13, 2023
Material agreement
8-K
Read ↗
Nov 6, 2023
Quarterly report
10-Q
Read ↗
Nov 6, 2023
Results announced
8-K
Read ↗
Sep 7, 2023
Executive or director change
8-K
Read ↗
Aug 7, 2023
Quarterly report
10-Q
Read ↗
Aug 7, 2023
Results announced
8-K
Read ↗
Jun 9, 2023
Executive or director changeShareholder vote
8-K
Read ↗
May 8, 2023
Quarterly report
10-Q
Read ↗
May 8, 2023
Results announced
8-K
Read ↗
Mar 29, 2023
Executive or director change
8-K
Read ↗
Mar 27, 2023
Material agreement
8-K
Read ↗
Mar 14, 2023
Executive or director change
8-K
Read ↗
Feb 21, 2023
Annual report
10-K
Read ↗
Feb 21, 2023
Results announced
8-K
Read ↗
Nov 1, 2022
Quarterly report
10-Q
Read ↗
Nov 1, 2022
Results announced
8-K
Read ↗
Oct 27, 2022
Executive or director change
8-K
Read ↗
Aug 8, 2022
Quarterly report
10-Q
Read ↗
Aug 8, 2022
Results announced
8-K
Read ↗
Jun 13, 2022
Executive or director changeShareholder vote
8-K
Read ↗
May 9, 2022
Quarterly report
10-Q
Read ↗
May 9, 2022
Results announced
8-K
Read ↗
Feb 15, 2022
Annual report
10-K
Read ↗
Feb 15, 2022
Results announced
8-K
Read ↗
Dec 20, 2021
Executive or director change
8-K
Read ↗
Nov 3, 2021
Quarterly report
10-Q
Read ↗
Nov 3, 2021
Results announced
8-K
Read ↗
Oct 14, 2021
Executive or director change
8-K
Read ↗
Jul 29, 2021
Quarterly report
10-Q
Read ↗
Jul 29, 2021
Results announced
8-K
Read ↗
Jun 14, 2021
Shareholder vote
8-K
Read ↗
Apr 27, 2021
Quarterly report
10-Q
Read ↗
Apr 27, 2021
Results announced
8-K
Read ↗
Apr 20, 2021
Material agreement
8-K
Read ↗
Feb 16, 2021
Annual report
10-K
Read ↗
Feb 16, 2021
Results announced
8-K
Read ↗
Oct 28, 2020
Quarterly report
10-Q
Read ↗
Oct 28, 2020
Results announced
8-K
Read ↗
Jul 27, 2020
Quarterly report
10-Q
Read ↗
Jul 27, 2020
Results announced
8-K
Read ↗
Jul 2, 2020
Material agreement
8-K
Read ↗
Jun 12, 2020
Executive or director changeShareholder vote
8-K
Read ↗
Apr 28, 2020
Quarterly report
10-Q
Read ↗
Apr 28, 2020
Results announced
8-K
Read ↗
Feb 26, 2020
Executive or director change
8-K
Read ↗
Feb 12, 2020
Annual report
10-K
Read ↗
Feb 12, 2020
Results announced
8-K
Read ↗
Jan 29, 2020
Executive or director change
8-K
Read ↗
Dec 27, 2019
Executive or director changeMaterial agreement
8-K
Read ↗
Dec 16, 2019
Acquisition or sale completedMaterial agreement
8-K
Read ↗
Nov 22, 2019
Material agreement
8-K
Read ↗
Oct 28, 2019
Quarterly report
10-Q
Read ↗
Oct 28, 2019
Results announced
8-K
Read ↗
Aug 30, 2019
Material agreement
8-K
Read ↗
Jul 29, 2019
Quarterly report
10-Q
Read ↗
Jul 29, 2019
Results announced
8-K
Read ↗
Jun 13, 2019
Executive or director changeShareholder vote
8-K
Read ↗
Jun 6, 2019
Material agreement
8-K
Read ↗
Apr 29, 2019
Quarterly report
10-Q
Read ↗
Apr 29, 2019
Results announced
8-K
Read ↗
Feb 25, 2019
Annual report
10-K
Read ↗
Feb 25, 2019
Results announced
8-K
Read ↗
Nov 7, 2018
Results announced
8-K
Read ↗
Nov 7, 2018
Quarterly report
10-Q
Read ↗
Sep 24, 2018
Material agreement
8-K
Read ↗
Sep 21, 2018
Material agreement
8-K
Read ↗
Sep 17, 2018
Material agreement
8-K
Read ↗
Aug 31, 2018
Material agreement
8-K
Read ↗
Aug 7, 2018
Results announced
8-K
Read ↗
Aug 7, 2018
Quarterly report
10-Q
Read ↗
Jun 1, 2018
Executive or director changeShareholder vote
8-K
Read ↗
May 8, 2018
Results announced
8-K
Read ↗
May 8, 2018
Quarterly report
10-Q
Read ↗
Mar 8, 2018
Results announced
8-K
Read ↗
Mar 8, 2018
Annual report
10-K
Read ↗
Jan 5, 2018
Material agreement
8-K
Read ↗
Dec 21, 2017
Executive or director change
8-K
Read ↗
Dec 18, 2017
Material agreement
8-K
Read ↗
Nov 13, 2017
Executive or director change
8-K
Read ↗
Nov 8, 2017
Results announced
8-K
Read ↗
Nov 8, 2017
Quarterly report
10-Q
Read ↗
Oct 2, 2017
Executive or director change
8-K
Read ↗
Aug 10, 2017
Results announced
8-K
Read ↗
Aug 10, 2017
Quarterly report
10-Q
Read ↗
Jul 27, 2017
Executive or director change
8-K
Read ↗
Jun 2, 2017
Executive or director changeShareholder vote
8-K
Read ↗
May 11, 2017
Results announced
8-K
Read ↗
May 11, 2017
Quarterly report
10-Q
Read ↗
May 4, 2017
Executive or director change
8-K
Read ↗
Mar 20, 2017
Executive or director change
8-K
Read ↗
Mar 10, 2017
Annual report
10-K
Read ↗
Dec 16, 2016
Material agreement
8-K
Read ↗
Nov 22, 2016
Quarterly report
10-Q
Read ↗
Oct 19, 2016
Share offering
424B4
Read ↗

Source: CRISPR Therapeutics AG's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on CRSP

Related datasets